Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure: a Randomized Controlled Pilot Trial (CAVAL US-AHF Study)

NCT04549701 is registered in ClinicalTrials.gov with Instituto Cardiovascular de Buenos Aires as lead sponsor.

NCT NCT04549701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04549701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure: a Randomized Controlled Pilot Trial (CAVAL US-AHF Study)
Lead sponsor
Instituto Cardiovascular de Buenos Aires
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2022
Completion date
February 28, 2023
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, heart failure